Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Twin peaks: The Omicron SARS-CoV-2 BA.1 and BA.2 epidemics in England
Paul Elliott, Oliver Eales, Nicholas Steyn, et al.
Science (2022) Vol. 376, Iss. 6600
Open Access | Times Cited: 103

Showing 26-50 of 103 citing articles:

Omicron BA.2 Lineage, the “Stealth” Variant: Is It Truly a Silent Epidemic? A Literature Review
Giorgio Tiecco, Samuele Storti, Stefania Arsuffi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 13, pp. 7315-7315
Open Access | Times Cited: 22
Competition of SARS-CoV-2 variants on the pandemic transmission dynamics
Jiaqi Chen, Changgui Gu, Zhongyuan Ruan, et al.
Chaos Solitons & Fractals (2023) Vol. 169, pp. 113193-113193
Open Access | Times Cited: 14
Pandemic preparedness: On the efficacy of non‐pharmaceutical interventions in COVID‐19 and about approaches to predict future pandemic viruses
Harald Brüssow
Microbial Biotechnology (2024) Vol. 17, Iss. 3
Open Access | Times Cited: 4
Clinical Manifestations of Infections with the Omicron Sub-Lineages BA.1, BA.2, and BA.5: A Retrospective Follow-Up Analysis of Public Health Data from Mecklenburg-Western Pomerania, Germany
Katja V. Goller, Janine Ziemann, Christian Köhler, et al.
Viruses (2024) Vol. 16, Iss. 3, pp. 454-454
Open Access | Times Cited: 4
The real-time infection hospitalisation and fatality risk across the COVID-19 pandemic in England
Thomas Ward, Martyn Fyles, Alex Glaser, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
The mechanisms of immune response and evasion by the main SARS-CoV-2 variants
Qiuli Chen, Jiawei Zhang, Peter Wang, et al.
iScience (2022) Vol. 25, Iss. 10, pp. 105044-105044
Open Access | Times Cited: 21
Low SARS-CoV-2 viral load among vaccinated individuals infected with Delta B.1.617.2 and Omicron BA.1.1.529 but not with Omicron BA.1.1 and BA.2 variants
Sivaprakasam T. Selvavinayagam, Yean K. Yong, Narcisse Joseph, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 18
Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial
Christian Taucher, Rajeka Lazarus, Hanna Dellago, et al.
Journal of Infection (2023) Vol. 87, Iss. 3, pp. 242-254
Closed Access | Times Cited: 11
SARS-CoV-2 emerging Omicron subvariants with a special focus on BF.7 and XBB.1.5 recently posing fears of rising cases amid ongoing COVID-19 pandemic
Kuldeep Dhama, Deepak Chandran, Hitesh Chopra, et al.
Journal of Experimental Biology and Agricultural Sciences (2022) Vol. 10, Iss. 6, pp. 1215-1221
Open Access | Times Cited: 16
Vaccine hesitancy promotes emergence of new SARS-CoV-2 variants
Shuanglin Jing, Russell Milne, Hao Wang, et al.
Journal of Theoretical Biology (2023) Vol. 570, pp. 111522-111522
Open Access | Times Cited: 9
Unraveling the Dynamics of Omicron (BA.1, BA.2, and BA.5) Waves and Emergence of the Deltacron Variant: Genomic Epidemiology of the SARS-CoV-2 Epidemic in Cyprus (Oct 2021–Oct 2022)
Andreas C. Chrysostomou, Bram Vrancken, Christos Haralambous, et al.
Viruses (2023) Vol. 15, Iss. 9, pp. 1933-1933
Open Access | Times Cited: 9
Antibody evasion associated with the RBD significant mutations in several emerging SARS-CoV-2 variants and its subvariants
Manojit Bhattacharya, Srijan Chatterjee, Sang‐Soo Lee, et al.
Drug Resistance Updates (2023) Vol. 71, pp. 101008-101008
Closed Access | Times Cited: 9
Estimating the impact of test-trace-isolate-quarantine systems on SARS-CoV-2 transmission in Australia
Freya M. Shearer, James M. McCaw, Gerard E. Ryan, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 8
Drivers of SARS-CoV-2 testing behaviour: a modelling study using nationwide testing data in England
Younjung Kim, Christl A. Donnelly, Pierre Nouvellet
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Estimating the impact of test–trace–isolate–quarantine systems on SARS-CoV-2 transmission in Australia
Freya M. Shearer, James M. McCaw, Gerard E. Ryan, et al.
Epidemics (2024) Vol. 47, pp. 100764-100764
Open Access | Times Cited: 2
Recent changes in the mutational dynamics of the SARS-CoV-2 main protease substantiate the danger of emerging resistance to antiviral drugs
Lena Parigger, A. Krassnigg, Tobias Schopper, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 12
Trends in Risk Factors and Symptoms Associated With SARS-CoV-2 and Rhinovirus Test Positivity in King County, Washington, June 2020 to July 2022
C. Hansen, Amanda C. Perofsky, Roy Burstein, et al.
JAMA Network Open (2022) Vol. 5, Iss. 12, pp. e2245861-e2245861
Open Access | Times Cited: 12
Mathematical assessment of the role of waning and boosting immunity against the BA.1 Omicron variant in the United States
Salman Safdar, Calistus N. Ngonghala, Abba B. Gumel
Mathematical Biosciences & Engineering (2022) Vol. 20, Iss. 1, pp. 179-212
Open Access | Times Cited: 12
RETRACTED: Gradual emergence followed by exponential spread of the SARS-CoV-2 Omicron variant in Africa
Carlo Fischer, Tongai Maponga, Anges Yadouléton, et al.
Science (2022) Vol. 378, Iss. 6623
Open Access | Times Cited: 11
Managing sources of error during pandemics
Simon Cauchemez, Paolo Bosetti, Benjamin J. Cowling
Science (2023) Vol. 379, Iss. 6631, pp. 437-439
Closed Access | Times Cited: 6
Persistence of the Omicron variant of SARS-CoV-2 in Australia: The impact of fluctuating social distancing
Sheryl L. Chang, Quang Dang Nguyen, Alexandra Martiniuk, et al.
PLOS Global Public Health (2023) Vol. 3, Iss. 4, pp. e0001427-e0001427
Open Access | Times Cited: 6
The Omicron-transformer: Rise of the subvariants in the age of vaccines
Travis Ren Teen Chia, Barnaby Edward Young, Po Ying Chia
Annals of the Academy of Medicine Singapore (2022) Vol. 51, Iss. 11, pp. 712-729
Open Access | Times Cited: 10
Circulating eosinophils associated with responsiveness to COVID-19 vaccine and the disease severity in patients with SARS-CoV-2 omicron variant infection
Zhuxian Zhu, Jixu Cai, Qiang Tang, et al.
BMC Pulmonary Medicine (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Inferring community transmission of SARS-CoV-2 in the United Kingdom using the ONS COVID-19 Infection Survey
Ruth McCabe, Gabriel Danelian, Jasmina Panovska‐Griffiths, et al.
Infectious Disease Modelling (2024) Vol. 9, Iss. 2, pp. 299-313
Open Access | Times Cited: 1
Evolution of illness severity in hospital admissions due to COVID-19, Québec, Canada, January to April 2022
Ernest Lo, Élise Fortin, Rodica Gilca, et al.
Canada Communicable Disease Report (2024) Vol. 50, Iss. 1/2, pp. 63-76
Open Access | Times Cited: 1

Scroll to top